SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is drawing attention around hopes for a recovery and a breakout from a prolonged trading range, with traders pointing to rising volume and repeated resistance tests. Bulls anticipate a short squeeze, while skeptics cite weak price action and warn that the token could keep falling; no specific catalyst is established.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRK is drawing attention around Starknets Bitcoin DeFi and privacy push, including strkBTC and STRK20, alongside its post-quantum security narrative. Traders are pairing those themes with recent price and volume strength, while some remain cautious about token unlocks and volatility.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is drawing attention amid a technical rebound and breakout attempts, with traders pointing to elevated short interest and speculating that covering could add buying pressure. Bulls see a turnaround and renewed enterprise AI demand, while skeptics remain focused on declining revenue and ongoing losses.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

AERO is drawing attention amid a rebound and anticipation of the AerodromeVelodrome merger and broader multi-chain rollout, which traders see as an expansion beyond Base with potential to increase liquidity and fee activity. Sentiment is largely bullish, though some traders question whether the move can hold and worry about a pullback or sell-the-news reaction.

TELUS Corp. is a telecommunications company, which engages in the provision of telecommunication services and products primarily for wireless and wireline voice and data. It operates through TELUS Technology Solutions (TTech) and Digitally-led Customer Experiences–TELUS International (DLCX) segments. The TTech segment includes network revenues and equipment sales arising from mobile technologies, data revenues, healthcare software and technology solutions, voice and other telecommunications services revenues, and equipment sales. The DLCX segment is composed of digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions, provided by TELUS International. The company was founded on October 4, 1990 and is headquartered in Vancouver, Canada.

Telus Corp.

TELUSs steep decline and repeated multi-year lows are drawing attention, with traders focused on the large dividend cut and concerns about losses, debt, management, and telecom competition. Some see the cut as necessary for deleveraging and the selloff as overdone, while others remain bearish and cite Starlink as a competitive threat.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEARs rally is being linked by traders to the launch of confidential perpetuals powered by Hyperliquid, alongside a broader AI-agent and cross-chain infrastructure narrative. The mood is largely bullish, though some traders warn of profit-taking and volatility after the sharp move.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs spectrum acquisition and Starlink Mobile ambitions have fueled fears that it could eventually compete with T-Mobile and other U.S. carriers, prompting a sharp selloff in telecom shares. Traders are divided between viewing the move as a meaningful long-term competitive threat and calling the reaction excessive because building a rival network would require substantial infrastructure and time.

ProShares Trust - ProShares Bitcoin ETF

ProShares Bitcoin Strategy ETF

BITO is drawing attention over sharply reduced monthly distributions and a persistently weak share price, with holders debating whether Bitcoins recovery can revive payouts. Some frustrated investors are considering selling, while others are accumulating in anticipation of a BTC rebound; no listed article directly verifies this discussion.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

Financials are under pressure amid rising Treasury yields and rate uncertainty, with traders also watching upcoming bank earnings for a possible turning point. The community is split between calling the sector oversold and expecting a rebound or rotation into banks, and warning that weak technicals and credit concerns could bring further declines.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

LUNC is drawing attention amid renewed speculation about token burns and supply reduction, including anticipated Market Module 2.0 changes and a possible USTC repeg, alongside broader Terra ecosystem development chatter. Bulls see a comeback setup, while skeptics point to the large supply, weak liquidity and limited follow-through; these catalysts remain uncertain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know

Agios faces a narrower growth path as tebapivat setbacks shift focus to mitapivat sales, SCD expansion and regulatory prospects.

Agios' Growth Story Hinges on Mitapivat's Commercial Expansion

AGIO's mitapivat is driving growth as Aqvesme gains traction, while an SCD opportunity and pipeline setbacks increase its importance.

Revolution Medicines (RVMD) Up 6.6% Since Last Earnings Report: Can It Continue?

Revolution Medicines (RVMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PR Newswire NEW YORK, Aug. 6, 2026 NEW YORK, Aug. 6, 2026...

AGIO Q2 Earnings Beat Estimates, Revenues Increase Year Over Year

Agios tops Q2 revenue and earnings estimates as Aqvesme's launch and Pyrukynd sales fuel growth, while advancing its hematology pipeline.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO PR Newswire NEW YORK, July 30, 2026 NEW YORK, July 30, 2026...

Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates

Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of +9.14% and +97.29%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals

HRMY, ACAD, BIIB, INSM and AGIO are set to report Q2 results, with positive Earnings ESPs suggesting potential earnings surprises.

Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss? 

Harmony Biosciences, Acadia, Biogen, Insmed and Agios show positive Earnings ESPs ahead of Q2 results, setting up closely watched earnings reports.

Neurocrine Gears Up to Report Q2 Earnings: What's in the Cards?

NBIX heads into Q2 results with a focus on Ingrezza sales, Crenessity growth and pipeline updates as investors watch key commercial and clinical progress.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Why Is AGIO Stock Falling Today? 

Equity

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

$AGIO   Still chasing an executive team of failures 
Fouse 
Goff 
Milanova
Jones 
Guehens
Your Merlin activities, saving Lancelot, won’t work here 
The FDA doesn’t give out fake approvals !!! 
@Merlintrader ….keep up the pump…has the check cleared ?

Pete lamb

$AGIO  when the past CEO, now Chairman of the board 
Bought 40,000 shares @$30 , on a secondary offering in 2019 , and still it sits at $30 ….an investor has to believe, that the board itself , as well as the past CEO , lacks intelligence to run a company . If you don’t believe me , ask Alex Karp !!!

$AGIO cry somewhere else @Merlintrader ..you must be a buddy of Goof Ball Brian Goff …
Only falling with all your pumping

Feed

News

Sentiment

Earnings

Fundamentals

Info

AGIO Agios Pharmaceuticals Inc

Fundamentals

Latest AGIO News